Publications by authors named "William Timmer"

Claim this Profile
A
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
Andrew E Sloan, Charles J Nock, Xiaobu Ye, Robert Buerki, Susan Chang, William Timmer

J Neurooncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases.
Hiroto Nakano, Takuto Miyamoto, Yelena Y Janjigian, Sohtaro Mine, Hiroaki Mitsuya, William C Timmer

World J Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, Mildred Galvez, Amy B Heimberger, William C Timmer

Neuro Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.
Stuart A Grossman, Carlos G Romo, Michelle A Rudek, Jeffrey Supko, Joy Fisher, William Timmer

Neuro Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Karen W Gripp, Lisa Schill, Lisa Schoyer, Beth Stronach, Anton M Bennett, William C Timmer

Am J Med Genet A· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Katherine A Rauen, Lisa Schoyer, Lisa Schill, Beth Stronach, John Albeck, William Timmer

Am J Med Genet A· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.
Margaret J Ochocinska, Berislav V Zlokovic, Peter C Searson, A Tamara Crowder, Richard P Kraig, William Timmer

Fluids Barriers CNS· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Principles and current strategies for targeting autophagy for cancer treatment.
Ravi K Amaravadi, Jennifer Lippincott-Schwartz, Xiao-Ming Yin, William A Weiss, Naoko Takebe, William Timmer

Clin Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.
Maitreyee Hazarika, Xiaoping Jiang, Qi Liu, Shwu-Luan Lee, Roshni Ramchandani, William Timmer

Clin Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
Michael Brave, Vicki Goodman, Edvardas Kaminskas, Ann Farrell, William Timmer

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis